Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
CHIR-99021 (CT99021): Selective GSK-3 Inhibitor for Stem Cel
2026-05-07
CHIR-99021 (CT99021) is a potent, selective inhibitor of GSK-3α/β widely used to modulate Wnt/β-catenin signaling and maintain embryonic stem cell pluripotency. Its unique specificity, high solubility in DMSO, and robust performance in pluripotency and differentiation protocols have made it a benchmark reagent in stem cell and regenerative medicine workflows.
-
MK-0812: Optimizing Monocyte Trafficking Inhibitor Workflows
2026-05-06
MK-0812 stands out as a potent, selective CCR2 antagonist for precisely disrupting monocyte recruitment and MCP-1 signaling in inflammation research. This article delivers actionable guidance on experimental design, data-driven troubleshooting, and protocol enhancements to make the most of APExBIO's MK-0812 in advanced immunology and gut–liver axis models.
-
AP20187: Chemical Inducer of Dimerization for Precision Cont
2026-05-06
AP20187 stands out as a powerful chemical inducer of dimerization, enabling tightly regulated gene expression and cell signaling in fusion protein systems. Its robust solubility, high purity, and proven in vivo activation make it a top-tier choice for conditional gene therapy and metabolic pathway studies.
-
Red Blood Cell Lysis Buffer: Precision Erythrocyte Removal f
2026-05-05
APExBIO's Red Blood Cell Lysis Buffer streamlines blood sample preparation with optimized ammonium chloride lysis, preserving nucleated cells for sensitive downstream analyses. Explore data-driven workflows, advanced applications, and troubleshooting insights that maximize assay fidelity and reproducibility.
-
ω-Agatoxin IVA TFA: Precision in Synaptic Transmission Resea
2026-05-05
ω-Agatoxin IVA TFA enables researchers to dissect P/Q-type Cav2.1 channel function with nanomolar specificity, transforming neuronal calcium current recording and synaptic transmission studies. Its unique selectivity profile, validated in both in vitro and in vivo systems, supports robust applications in epilepsy modeling and neuroprotection workflows.
-
Veratridine as a Precision Tool for Cardiac and Neuro Assays
2026-05-04
Explore Veratridine as a voltage-gated sodium channel opener in precision sodium channel dynamics research. This in-depth article uniquely examines Veratridine’s impact on chamber-specific cardiomyocyte assays, bridging neurophysiology and cardiac disease modeling.
-
Ceftazidime: Mechanistic Precision and Resistance Insights f
2026-05-04
Explore the science behind Ceftazidime, a third-generation cephalosporin, and its evidence-based role in Gram-negative bacterial infection research. This article uniquely analyzes resistance transmission dynamics to guide optimal assay design and interpretation.
-
Phosbind Biotin: Precision Phosphorylation Detection Beyond
2026-05-03
Explore how Phosbind Biotin leverages dinuclear metal complex phosphate binding for advanced, antibody-independent Western Blot detection of phosphorylated proteins. This article uniquely connects molecular assay innovation to stress signaling research, with protocol guidance and analysis grounded in recent plant biology breakthroughs.
-
Chamber-Specific Cardiomyocyte Induction from hPSCs: RV Mode
2026-05-02
Saito et al. introduce a refined protocol enabling the directed differentiation of human pluripotent stem cells into right ventricular-like cardiomyocytes. This methodological advance provides a foundation for chamber-specific disease modeling and comparative cardiac research.
-
Ferrostatin-1 (Fer-1): Precision Inhibition of Ferroptosis A
2026-05-01
Ferrostatin-1 (Fer-1) is a potent, selective ferroptosis inhibitor essential for dissecting iron-dependent oxidative cell death in cancer and neurodegeneration. With an EC50 of ~60 nM against erastin-induced ferroptosis, Fer-1 enables reproducible, workflow-compatible assays and mechanistic research. Its unique solubility and storage profile make it a critical tool for oxidative lipid damage inhibition studies.
-
Reactive Oxygen Species Assay Kit: Optimizing ROS Quantifica
2026-05-01
Boost the accuracy and reproducibility of oxidative stress measurement assays using the APExBIO Reactive Oxygen Species Assay Kit. This guide delivers actionable workflow enhancements, advanced application insights, and troubleshooting strategies tailored for apoptosis, cancer, and redox biology research.
-
Alda 1: Advancing ALDH2 Activation for Cardiac Regeneration
2026-04-30
This article explores the transformative role of Alda 1, a potent ALDH2 activator from APExBIO, in enabling next-generation research on cardioprotection, cardiac regeneration, and radiation-induced dermatitis mitigation. Integrating mechanistic insights, recent in vivo findings, and strategic protocol guidance, we delineate how Alda 1 is redefining translational research workflows and expanding the boundaries of aldehyde detoxification science.
-
ZNF263 Drives Autophagy and Proliferation in Intrahepatic Ch
2026-04-30
This study identifies Zinc Finger Protein 263 (ZNF263) as a key driver of intrahepatic cholangiocarcinoma (ICC) cell proliferation, acting through direct transcriptional upregulation of ULK1 and subsequent enhancement of autophagy. These findings clarify a mechanistic link between transcriptional control and autophagy in ICC, offering new directions for targeted therapeutic strategies.
-
FLAG tag Peptide (DYKDDDDK): Precision in Protein Purificati
2026-04-29
The FLAG tag Peptide (DYKDDDDK) unlocks high-specificity detection and gentle purification for recombinant proteins, outperforming conventional tags in complex workflows. This guide delivers actionable, evidence-based protocols and troubleshooting strategies that leverage APExBIO’s peptide for maximal yield and reproducibility.
-
Veratridine in Mechanistic Excitotoxicity: From Sodium Chann
2026-04-29
Explore how Veratridine, a voltage-gated sodium channel opener, uniquely enables mechanistic dissection of excitotoxicity and disease modeling. This article delivers advanced protocol guidance, translational insight, and a critical review of contemporary research tools.